Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "Acta Neurologica Belgica"
DOI: 10.1007/s13760-019-01187-3
Abstract: Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory, demyelinating disease of the central nervous system that is characterized by severe attacks of optic neuritis and myelitis [1]. Because 80–90% of patients with NMOSD experience relapsing…
read more here.
Keywords:
mri scans;
spectrum disorder;
neuromyelitis optica;
patients nmosd ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2017.07.004
Abstract: BACKGROUND Painful tonic spasm (PTS) is a common symptom in patients with neuromyelitis optica spectrum disorders (NMOSD). This study aimed to obtain further insights into the prevalence, characteristics, and treatment of PTS in patients with…
read more here.
Keywords:
treatment;
painful tonic;
neuromyelitis optica;
tonic spasm ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2019.05.011
Abstract: BACKGROUND Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory and autoimmune disorder of the central nervous system that typically presents with optic neuritis and myelitis. Azathioprine (AZA) is one of the available immunotherapies with purported…
read more here.
Keywords:
systematic review;
spectrum disorder;
neuromyelitis optica;
patients nmosd ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2020.102080
Abstract: BACKGROUND The bone health in neuromyelitis optica spectrum disorder with aquaporin-4 immunoglobulin G antibodies (NMOSD-AQP4) have not been fully evaluated. To evaluate the prevalence of fractures and bone loss in patients with NMOSD-AQP4 compared to…
read more here.
Keywords:
risk;
health neuromyelitis;
bone health;
patients nmosd ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "Neurophysiologie Clinique"
DOI: 10.1016/j.neucli.2018.05.015
Abstract: Objectives The neuromyelitis optica spectrum disorder (NMOSD) was differentiated from relapsing-remitting multiple sclerosis (MS) by clinical, laboratory and physiopathological findings, including the presence of anti-aquaporin 4 (AQP4-Ab) antibody. Visual evoked potentials (VEP) are often used…
read more here.
Keywords:
visual evoked;
spectrum disorder;
neuromyelitis optica;
multiple sclerosis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "The Lancet Neurology"
DOI: 10.1016/s1474-4422(20)30100-9
Abstract: www.thelancet.com/neurology Vol 19 May 2020 371 for the treatment of NMOSD, done at six hospitals in China. Azathioprine was the first therapy observed to reduce the risk of relapses in patients with NMOSD, and although…
read more here.
Keywords:
management intracranial;
intensive medical;
neurology;
risk ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2022.958441
Abstract: Background The existence, frequency, and features of cognitive impairment (CI) in patients with neuromyelitis optica spectrum disorder (NMOSD) are still debated. A precise classification and characterization of cognitive phenotypes in patients with NMOSD are lacking.…
read more here.
Keywords:
neuromyelitis optica;
optica spectrum;
disability;
spectrum disorder ... See more keywords